Literature Sharing: Multiplex Fluorescence Immunotechnology Reveals Colorectal Cancer Biomarkers
The authors innovatively used multiplex fluorescence immunohistochemistry (mIHC) technology, using tumor tissue and adjacent normal tissue from 84 colorectal cancer patients to construct tissue microarrays (TMA), simultaneously detecting the expression levels of cancer stem cell marker CD133, immune checkpoint molecule PD-L1, tumor-associated antigen HER2, and macrophage marker CD68, combining clinicopathological features with 7-year follow-up data to explore the diagnostic and prognostic value of these markers in colorectal cancer, providing new technical support and theoretical basis for precise diagnosis and treatment of colorectal cancer.